Changing the lives of dogs with osteoarthritis

At Vetosine we are developing and commercializing a first-in-class disease modifying osteoarthritis drug (DMOAD) for animals, with an initial focus on dogs.

Vetosine’s proprietary adenosine-based treatment has the potential to transform the management of osteoarthritis in companion animals and significantly improve quality of life for millions of pets and their owners.